These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9773124)
1. [Interaction between the sympathetic and renin-angiotensin system]. K-Laflamme A; de Champlain J Therapie; 1998; 53(3):245-52. PubMed ID: 9773124 [TBL] [Abstract][Full Text] [Related]
2. Effects of antihypertensive therapies on the sympathetic nervous system. de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251 [TBL] [Abstract][Full Text] [Related]
3. Interaction between the adrenergic and renin-angiotensin-aldosterone-systems. van Zwieten PA; de Jonge A Postgrad Med J; 1986; 62 Suppl 1():23-7. PubMed ID: 3534860 [TBL] [Abstract][Full Text] [Related]
4. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats. Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930 [TBL] [Abstract][Full Text] [Related]
5. [Sympathetic nervous system and endothelial function in heart failure]. Binggeli C; Wenzel RR; Noll G Praxis (Bern 1994); 1996 Feb; 85(8):234-44. PubMed ID: 8701190 [TBL] [Abstract][Full Text] [Related]
6. AT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease. Nap A; Balt JC; Mathy MJ; Van Zwieten PA Auton Autacoid Pharmacol; 2003; 23(5-6):285-96. PubMed ID: 15255813 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease. Mancia G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Grassi G J Hypertens Suppl; 2006 Mar; 24(1):S51-6. PubMed ID: 16601574 [TBL] [Abstract][Full Text] [Related]
8. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988 [TBL] [Abstract][Full Text] [Related]
9. [Sympathy and heartache: new information on the sympathetic nervous system]. Spieker LE; Binggeli C; Lüscher TF; Noll G Schweiz Med Wochenschr; 1997 Nov; 127(48):1986-92. PubMed ID: 9490465 [TBL] [Abstract][Full Text] [Related]
10. Tissue angiotensin generation and regulation of vascular tone. Cockcroft JR; O'Kane KP; Webb DJ Pharmacol Ther; 1995 Feb; 65(2):193-213. PubMed ID: 7792315 [TBL] [Abstract][Full Text] [Related]
11. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211 [TBL] [Abstract][Full Text] [Related]
12. Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model. Nap A; Belterman CN; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):220-7. PubMed ID: 14689369 [TBL] [Abstract][Full Text] [Related]
13. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy]. Castro-Chaves P; Leite-Moreira AF Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure. Brooks DP; Ruffolo RR J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Re RN Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259 [TBL] [Abstract][Full Text] [Related]
16. [Activity of the sympathetic nervous system and of the renin-angiotensin system in the acute stage of myocardial infarction]. Renard M; Blankoff I; Chami J; Dereppe H; Chi Hoang H; Giot JM; Dramaix M; Bernard R Bull Mem Acad R Med Belg; 1991; 146(6-7):305-11. PubMed ID: 1815813 [TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321 [TBL] [Abstract][Full Text] [Related]
19. Impaired baroreflex sensitivity and responses to angiotensin converting enzyme inhibitor in salt-induced hypertension and its prevention by dietary calcium supplement in Sprague-Dawley rats. Ladipo CO; Egbe PE; Ibu JO Afr J Med Med Sci; 2006 Mar; 35(1):29-36. PubMed ID: 17209324 [TBL] [Abstract][Full Text] [Related]
20. Intravenous delivery of PTH/PTHrP type 1 receptor cDNA to rats decreases heart rate, blood pressure, renal tone, renin angiotensin system, and stress-induced cardiovascular responses. Fritsch S; Lindner V; Welsch S; Massfelder T; Grima M; Rothhut S; Barthelmebs M; Helwig JJ J Am Soc Nephrol; 2004 Oct; 15(10):2588-600. PubMed ID: 15466263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]